Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

OBJECTIVES: To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO). DESIGN, SETTING, AND PATIENTS: Phase IV, prospective, open-label, single-arm trial in 11 Spanish hospitals. Treatment-...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Arumi, Jose, Gómez-Ulla, Francisco, Amparo, Navea, Cervera, Enrique, Fonollosa, Alex, Arias, Luis, Araiz, Javier, Donate, Juan, de Figueroa, Marta Suárez, Manzanas, Lucia, Crespí, Jaume, Gallego, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204200/
https://www.ncbi.nlm.nih.gov/pubmed/30405907
http://dx.doi.org/10.1155/2018/8310350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204200/
https://www.ncbi.nlm.nih.gov/pubmed/30405907
http://dx.doi.org/10.1155/2018/8310350

Ejemplares similares